Cargando…
Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy
Tumor-derived membrane vesicles (TDMVs) are non-invasive, chemotactic, easily obtained characteristics and contain various tumor-borne substances, such as nucleic acid and proteins. The unique properties of tumor cells and membranes make them widely used in drug loading, membrane fusion and vaccines...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318328/ https://www.ncbi.nlm.nih.gov/pubmed/35890175 http://dx.doi.org/10.3390/ph15070876 |
_version_ | 1784755263991971840 |
---|---|
author | Xu, Jiabin Cao, Wenqiang Wang, Penglai Liu, Hong |
author_facet | Xu, Jiabin Cao, Wenqiang Wang, Penglai Liu, Hong |
author_sort | Xu, Jiabin |
collection | PubMed |
description | Tumor-derived membrane vesicles (TDMVs) are non-invasive, chemotactic, easily obtained characteristics and contain various tumor-borne substances, such as nucleic acid and proteins. The unique properties of tumor cells and membranes make them widely used in drug loading, membrane fusion and vaccines. In particular, personalized vectors prepared using the editable properties of cells can help in the design of personalized vaccines. This review focuses on recent research on TDMV technology and its application in personalized immunotherapy. We elucidate the strengths and challenges of TDMVs to promote their application from theory to clinical practice. |
format | Online Article Text |
id | pubmed-9318328 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-93183282022-07-27 Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy Xu, Jiabin Cao, Wenqiang Wang, Penglai Liu, Hong Pharmaceuticals (Basel) Review Tumor-derived membrane vesicles (TDMVs) are non-invasive, chemotactic, easily obtained characteristics and contain various tumor-borne substances, such as nucleic acid and proteins. The unique properties of tumor cells and membranes make them widely used in drug loading, membrane fusion and vaccines. In particular, personalized vectors prepared using the editable properties of cells can help in the design of personalized vaccines. This review focuses on recent research on TDMV technology and its application in personalized immunotherapy. We elucidate the strengths and challenges of TDMVs to promote their application from theory to clinical practice. MDPI 2022-07-16 /pmc/articles/PMC9318328/ /pubmed/35890175 http://dx.doi.org/10.3390/ph15070876 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Review Xu, Jiabin Cao, Wenqiang Wang, Penglai Liu, Hong Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title_full | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title_fullStr | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title_full_unstemmed | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title_short | Tumor-Derived Membrane Vesicles: A Promising Tool for Personalized Immunotherapy |
title_sort | tumor-derived membrane vesicles: a promising tool for personalized immunotherapy |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9318328/ https://www.ncbi.nlm.nih.gov/pubmed/35890175 http://dx.doi.org/10.3390/ph15070876 |
work_keys_str_mv | AT xujiabin tumorderivedmembranevesiclesapromisingtoolforpersonalizedimmunotherapy AT caowenqiang tumorderivedmembranevesiclesapromisingtoolforpersonalizedimmunotherapy AT wangpenglai tumorderivedmembranevesiclesapromisingtoolforpersonalizedimmunotherapy AT liuhong tumorderivedmembranevesiclesapromisingtoolforpersonalizedimmunotherapy |